Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Position-Directed Budesonide Nasal Drops for Olfactory Dysfunction in Eosinophilic Chronic Rhinosinusitis: A Randomized Controlled Trial

NCT07386873 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT07386873
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07386873 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Position-Directed Budesonide Nasal Drops for Olfactory Dysfunction in Eosinophilic Chronic Rhinosinusitis: A Randomized Controlled Trial
Lead sponsor
Peking University Third Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 25, 2026
Completion date
December 31, 2028
Enrollment
78 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic rhinosinusitis (crs), olfactory dysfunction